Association between the TNF-2 allele and a better survival in cardiogenic shock

Chest

Volumn 125, Issue 6, 2004, Pages 2232-2237

  Appoloni, Olivier ^a   Dupont, Etienne ^a   Vandercruys, Marleen ^a   Andrien, Marc ^a   Duchateau, Jean ^b   Vincent, Jean Louis ^a  

^a ERASME HOSPITAL   (Belgium)

^b BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cardiogenic shock; Cytokines; Interferon ; Polymorphism; Tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; LYMPHOTOXIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ARTICLE; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC POLYMORPHISM; HUMAN; INTENSIVE CARE; INTRON; MALE; MORTALITY; OBSERVATION; PHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; SURVIVAL;

EID: 2942705711     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.6.2232     Document Type: Article

References (30)

1. Califf RM, Bengtson JR. Cardiogenic shock. N Engl J Med 1994; 330:1724-1730
2. Goldberg RJ, Samad NA, Yarzebski J, et al. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999; 340:1162-1168
3. Parrillo JE, Burch C, Shelhamer JH, et al. A circulating myocardial depressant substance in humans with septic shock. J Clin Invest 1985; 76:1539-1553
4. Michie HR, Manogue KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318:1481-1486
5. Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323:236-241
6. McMurray J, Abdullah I, Dargie HJ, et al. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J 1991; 66:356-358
7. Bryant D, Becker L, Richardson J, et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α. Circulation 1998; 97:1375-1381
8. Bozkurt B, Kribbs SB, Clubb FJ Jr, et al. Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998; 97:1382-1391
9. Kapadia S, Torre-Amione G, Yokoyama T, et al. Soluble TNF binding proteins modulate the negative inotropic properties of TNF-α in vitro. Am J Physiol 1995; 268:H517-H525
10. Bozkurt B, Torre-Amione G, Warren MS, et al. Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation 2001; 103:1044-1047
11. Sliwa K, Skudicky D, Candy G, et al. Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy. Lancet 1998; 351:1091-1093
12. Woods A, Brull DJ, Humphries SE, et al. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J 2000; 21:1574-1583
13. Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997; 94:3195-3199
14. Mira JP, Cariou A, Grall F, et al. Association of TNF2, a TNF-α promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999; 282: 561-568
15. Tang GJ, Huang SL, Yien HW, et al. Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 2000; 28:2733-2736
16. Appoloni O, Dupont E, Andrien M, et al. Association of TNF2, a TNFα promoter polymorphism, with plasma TNFα levels and mortality in septic shock. Am J Med 2001; 110: 486-488
17. Densem CG, Hutchinson IV, Yonan N, et al. Tumour necrosis factor α gene polymorphism: a predisposing factor to non-ischaemic myocardial dysfunction? Heart 2002; 87:153-155
18. Le Gall J-R, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963
19. Vincent JL, de Mendonça A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/ failure in intensive care units: results of a multicentric, prospective study. Crit Care Med 1998; 26:1793-1800
20. Strachan T, Read AP. Human molecular genetics. Oxford, UK: BIOS Scientific, 1996; 499
21. Yokoyama T, Vaca L, Rossen RD, et al. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest 1993; 92:2303-2312
22. Finkel MS, Oddis CV, Jacob TD, et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257:378-389
23. Krown KA, Page MT, Nguyen C, et al. Tumor necrosis factor α-induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 1996; 98:2854-2865
24. Matsubara T, Ziff M. Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol 1986; 137:3295-3298
25. Anker SD, Egerer KR, Volk HD, et al. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol 1997; 79:1426-1430
26. Baumgarten G, Knuefermann P, Kalra D, et al. Load-dependent and -independent regulation of proinflammatory cytokine and cytokine receptor gene expression in the adult mammalian heart. Circulation 2002; 105:2192-2197
27. Afanasyeva M, Wang Y, Kaya Z, et al. Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-γ-independent pathway. Circulation 2001; 104:3145-3151
28. Aukrust P, Ueland T, Lien E, et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1999; 83:376-382
29. Das UN. Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction. Mol Cell Biochem 2000; 215:145-152
30. Andreotti F, Porto I, Crea F, et al. Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart 2002; 87:107-112